{"id":51,"date":"2019-09-18T16:19:30","date_gmt":"2019-09-18T16:19:30","guid":{"rendered":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/chapter\/1-10-therapeutic-levels\/"},"modified":"2025-01-16T22:29:14","modified_gmt":"2025-01-16T22:29:14","slug":"1-10-therapeutic-levels","status":"publish","type":"chapter","link":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/chapter\/1-10-therapeutic-levels\/","title":{"raw":"1.10 Therapeutic Levels","rendered":"1.10 Therapeutic Levels"},"content":{"raw":"Now that the concepts of dose-response, onset, peak, and duration have been discussed, it is important to understand the therapeutic window and therapeutic index.\n<h2>Therapeutic Window<\/h2>\nFor every drug, there exists a dose that is minimally effective (the Effective Concentration) and another dose that is toxic (the Toxic Concentration). Between these doses is the <strong>[pb_glossary id=\"479\"]therapeutic window[\/pb_glossary]<\/strong>, where the safest and most effective treatment will occur. For example, see Figure 1.9<sup>[footnote]\u201c<a href=\"https:\/\/commons.wikimedia.org\/wiki\/File:Theuraputic_window.png\" target=\"_blank\" rel=\"noopener\">Therapeutic Window<\/a>\u201d\u00a0by Shefaa Alasfoor is licensed under\u00a0<a href=\"https:\/\/creativecommons.org\/licenses\/by-sa\/3.0\/\" target=\"_blank\" rel=\"noopener noreferrer\">CC BY-SA 3.0<\/a><span style=\"font-size: 12.8px\">[\/footnote]<\/span><\/sup>\u00a0for an illustration of the therapeutic window for warfarin, a medication used to prevent blood clotting.\u00a0Too much warfarin administered causes bleeding and vitamin K is required as an antidote. Conversely, not enough warfarin administered for a client's condition can cause clotting. Think of the therapeutic window (the green area on the graph) as the \"perfect dose,\" where clotting is prevented and yet bleeding does not occur.\n\n[caption id=\"attachment_50\" align=\"aligncenter\" width=\"282\"]<img class=\"wp-image-50\" title=\"&quot;Therapeutic Window&quot; by Shefaa Alasfoor is licensed under CC BY-SA 3.0\" src=\"https:\/\/pressbooks.ccconline.org\/accdigitalmarketing\/wp-content\/uploads\/sites\/219\/2019\/09\/image11-300x214.png\" alt=\"Image of Therapeutic Window, shown as a graph with textual labels\" width=\"282\" height=\"201\"> Figure 1.9 Therapeutic Window[\/caption]\n\nThe effect of warfarin is monitored using a blood test called international normalized ration (INR). For clients receiving warfarin, nurses vigilantly monitor their INR levels to ensure the dosage appropriately reaches their therapeutic window and does not place them at risk for bleeding or clotting.\n<h3>Peak and Trough Levels<\/h3>\nNow let's apply the idea of therapeutic window to the administration of medications requiring the monitoring of peak and trough levels, which is commonly required in the administration of specific IV antibiotics. The dosage of these medications is <strong>[pb_glossary id=\"721\"]titrated[\/pb_glossary]<\/strong>, meaning adjusted for safety, to achieve a desired therapeutic effect for the client. Titration is accomplished by closely monitoring the peak and trough levels of the medication. A drug is said to be within the \"therapeutic window\" when the serum blood levels of an active drug remain consistently above the level of effective concentration (so that the medication is achieving its desired therapeutic effect) and consistently below the toxic level (so that no toxic effects are occurring).\n\nA <strong>[pb_glossary id=\"477\"]peak[\/pb_glossary]<\/strong> drug level is drawn after the medication is administered and is known to be at the highest level in the bloodstream. A <strong>[pb_glossary id=\"722\"]trough[\/pb_glossary]<\/strong> level is drawn when the drug is at its lowest in the bloodstream, right before the next scheduled dose is given. Medications have a predicted reference range of normal values for peak and trough levels. These numbers assist the pharmacist and provider in gauging how the body is metabolizing, protein-binding, and excreting the drug and are used to adjust the prescribed dose to keep the medication within the therapeutic window. When administering IV medications that require peak or trough levels, it is vital for the nurse to plan the administration of the medication according to the timing of these blood draws.<sup>[footnote]This work is a derivative of <a href=\"https:\/\/med.libretexts.org\/Bookshelves\/Pharmacology_and_Medicine\/Book%3A_Principles_of_Pharmacology_(OCW)\" target=\"_blank\" rel=\"noopener noreferrer\">Principles of Pharmacology<\/a> by <a href=\"https:\/\/libretexts.org\/\" target=\"_blank\" rel=\"noopener noreferrer\">LibreTexts<\/a> and is licensed under <a href=\"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/\" target=\"_blank\" rel=\"noopener noreferrer\">CC BY-NC-SA 4.0<\/a>[\/footnote]<\/sup>\n<h2>Therapeutic Index<\/h2>\nThe<strong> [pb_glossary id=\"480\"]therapeutic index[\/pb_glossary] <\/strong>is a quantitative measurement of the relative safety of a drug. It is a comparison of the amount of drug that produces a therapeutic effect versus the amount of drug that produces a toxic effect.\n<ul>\n \t<li>A large (or high) therapeutic index number means there is a wide therapeutic window between the effective concentration and the toxic concentration of a medication, so the drug is relatively safe.<\/li>\n \t<li>A small (or low) therapeutic index number means there is a narrow therapeutic window between the effective concentration and the toxic concentration. A drug with a narrow therapeutic range (i.e., having little difference between toxic and therapeutic doses) often has the dosage titrated according to measurements of the actual blood levels achieved in the person taking it.<\/li>\n<\/ul>\nFor example, phenytoin has a narrow therapeutic index between the effective and toxic concentrations. Clients who start taking phenytoin to control seizures have frequent peak and trough drug levels to ensure they achieve steady state with a therapeutic dose to prevent seizures without reaching toxic levels.\n<div class=\"__UNKNOWN__\">\n<div class=\"textbox textbox--examples\"><header class=\"textbox__header\">\n<h2>Critical Thinking Activity 1.10<img class=\"alignright wp-image-36\" style=\"font-size: 14.4px;font-family: 'Encode Sans', sans-serif\" src=\"https:\/\/pressbooks.ccconline.org\/accdigitalmarketing\/wp-content\/uploads\/sites\/219\/2025\/01\/ORN-Icons_internet-copy_internet-copy-300x300-1.png\" alt=\"Image of a circle containing a speech bubble with a question mark in it.\" width=\"200\" height=\"200\"><\/h2>\n<\/header>\n<div class=\"textbox__content\" style=\"text-align: left\">\n\nMr. Parker has been receiving gentamicin 80 mg IV three times daily to treat his infective endocarditis. He has his gentamicin level checked one hour after the end of his previous gentamicin infusion was completed. The result is 30 mcg\/mL. Access the information below to determine the nurse's course of action.\n\n<a class=\"arrow\" href=\"https:\/\/medlineplus.gov\/ency\/article\/003430.htm\" target=\"_blank\" rel=\"noopener noreferrer\">View information on therapeutic drug levels.<\/a>\n\n<em> (After accessing the information, be sure to select \u201cclick to keep reading\u201d in order to view drugs that are commonly checked, their target levels, and what abnormal results mean.)<\/em>\n\nBased on the results in the above client scenario, what action will the nurse take based on the result of the gentamicin level of 30 mcg\/mL?\n\n<\/div>\nNote: Answers to the Critical Thinking activities can be found in the \"<a href=\"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/chapter\/chapter-1\/\" target=\"_blank\" rel=\"noopener\">Answer Key<\/a>\" section at the end of the book.\n\n&nbsp;\n\n<\/div>\n<\/div>","rendered":"<p>Now that the concepts of dose-response, onset, peak, and duration have been discussed, it is important to understand the therapeutic window and therapeutic index.<\/p>\n<h2>Therapeutic Window<\/h2>\n<p>For every drug, there exists a dose that is minimally effective (the Effective Concentration) and another dose that is toxic (the Toxic Concentration). Between these doses is the <strong><a class=\"glossary-term\" aria-haspopup=\"dialog\" aria-describedby=\"definition\" href=\"#term_51_479\">therapeutic window<\/a><\/strong>, where the safest and most effective treatment will occur. For example, see Figure 1.9<sup><a class=\"footnote\" title=\"\u201cTherapeutic Window\u201d\u00a0by Shefaa Alasfoor is licensed under\u00a0CC BY-SA 3.0\" id=\"return-footnote-51-1\" href=\"#footnote-51-1\" aria-label=\"Footnote 1\"><sup class=\"footnote\">[1]<\/sup><\/a><\/span><\/sup>\u00a0for an illustration of the therapeutic window for warfarin, a medication used to prevent blood clotting.\u00a0Too much warfarin administered causes bleeding and vitamin K is required as an antidote. Conversely, not enough warfarin administered for a client&#8217;s condition can cause clotting. Think of the therapeutic window (the green area on the graph) as the &#8220;perfect dose,&#8221; where clotting is prevented and yet bleeding does not occur.<\/p>\n<figure id=\"attachment_50\" aria-describedby=\"caption-attachment-50\" style=\"width: 282px\" class=\"wp-caption aligncenter\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-50\" title=\"&quot;Therapeutic Window&quot; by Shefaa Alasfoor is licensed under CC BY-SA 3.0\" src=\"https:\/\/pressbooks.ccconline.org\/accdigitalmarketing\/wp-content\/uploads\/sites\/219\/2019\/09\/image11-300x214.png\" alt=\"Image of Therapeutic Window, shown as a graph with textual labels\" width=\"282\" height=\"201\" srcset=\"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-content\/uploads\/sites\/219\/2019\/09\/image11-300x214.png 300w, https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-content\/uploads\/sites\/219\/2019\/09\/image11-65x46.png 65w, https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-content\/uploads\/sites\/219\/2019\/09\/image11-225x160.png 225w, https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-content\/uploads\/sites\/219\/2019\/09\/image11-350x250.png 350w, https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-content\/uploads\/sites\/219\/2019\/09\/image11.png 380w\" sizes=\"auto, (max-width: 282px) 100vw, 282px\" \/><figcaption id=\"caption-attachment-50\" class=\"wp-caption-text\">Figure 1.9 Therapeutic Window<\/figcaption><\/figure>\n<p>The effect of warfarin is monitored using a blood test called international normalized ration (INR). For clients receiving warfarin, nurses vigilantly monitor their INR levels to ensure the dosage appropriately reaches their therapeutic window and does not place them at risk for bleeding or clotting.<\/p>\n<h3>Peak and Trough Levels<\/h3>\n<p>Now let&#8217;s apply the idea of therapeutic window to the administration of medications requiring the monitoring of peak and trough levels, which is commonly required in the administration of specific IV antibiotics. The dosage of these medications is <strong><a class=\"glossary-term\" aria-haspopup=\"dialog\" aria-describedby=\"definition\" href=\"#term_51_721\">titrated<\/a><\/strong>, meaning adjusted for safety, to achieve a desired therapeutic effect for the client. Titration is accomplished by closely monitoring the peak and trough levels of the medication. A drug is said to be within the &#8220;therapeutic window&#8221; when the serum blood levels of an active drug remain consistently above the level of effective concentration (so that the medication is achieving its desired therapeutic effect) and consistently below the toxic level (so that no toxic effects are occurring).<\/p>\n<p>A <strong><a class=\"glossary-term\" aria-haspopup=\"dialog\" aria-describedby=\"definition\" href=\"#term_51_477\">peak<\/a><\/strong> drug level is drawn after the medication is administered and is known to be at the highest level in the bloodstream. A <strong><a class=\"glossary-term\" aria-haspopup=\"dialog\" aria-describedby=\"definition\" href=\"#term_51_722\">trough<\/a><\/strong> level is drawn when the drug is at its lowest in the bloodstream, right before the next scheduled dose is given. Medications have a predicted reference range of normal values for peak and trough levels. These numbers assist the pharmacist and provider in gauging how the body is metabolizing, protein-binding, and excreting the drug and are used to adjust the prescribed dose to keep the medication within the therapeutic window. When administering IV medications that require peak or trough levels, it is vital for the nurse to plan the administration of the medication according to the timing of these blood draws.<sup><a class=\"footnote\" title=\"This work is a derivative of Principles of Pharmacology by LibreTexts and is licensed under CC BY-NC-SA 4.0\" id=\"return-footnote-51-2\" href=\"#footnote-51-2\" aria-label=\"Footnote 2\"><sup class=\"footnote\">[2]<\/sup><\/a><\/sup><\/p>\n<h2>Therapeutic Index<\/h2>\n<p>The<strong> <a class=\"glossary-term\" aria-haspopup=\"dialog\" aria-describedby=\"definition\" href=\"#term_51_480\">therapeutic index<\/a> <\/strong>is a quantitative measurement of the relative safety of a drug. It is a comparison of the amount of drug that produces a therapeutic effect versus the amount of drug that produces a toxic effect.<\/p>\n<ul>\n<li>A large (or high) therapeutic index number means there is a wide therapeutic window between the effective concentration and the toxic concentration of a medication, so the drug is relatively safe.<\/li>\n<li>A small (or low) therapeutic index number means there is a narrow therapeutic window between the effective concentration and the toxic concentration. A drug with a narrow therapeutic range (i.e., having little difference between toxic and therapeutic doses) often has the dosage titrated according to measurements of the actual blood levels achieved in the person taking it.<\/li>\n<\/ul>\n<p>For example, phenytoin has a narrow therapeutic index between the effective and toxic concentrations. Clients who start taking phenytoin to control seizures have frequent peak and trough drug levels to ensure they achieve steady state with a therapeutic dose to prevent seizures without reaching toxic levels.<\/p>\n<div class=\"__UNKNOWN__\">\n<div class=\"textbox textbox--examples\">\n<header class=\"textbox__header\">\n<h2>Critical Thinking Activity 1.10<img loading=\"lazy\" decoding=\"async\" class=\"alignright wp-image-36\" style=\"font-size: 14.4px;font-family: 'Encode Sans', sans-serif\" src=\"https:\/\/pressbooks.ccconline.org\/accdigitalmarketing\/wp-content\/uploads\/sites\/219\/2025\/01\/ORN-Icons_internet-copy_internet-copy-300x300-1.png\" alt=\"Image of a circle containing a speech bubble with a question mark in it.\" width=\"200\" height=\"200\" srcset=\"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-content\/uploads\/sites\/219\/2025\/01\/ORN-Icons_internet-copy_internet-copy-300x300-1.png 300w, https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-content\/uploads\/sites\/219\/2025\/01\/ORN-Icons_internet-copy_internet-copy-300x300-1-150x150.png 150w, https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-content\/uploads\/sites\/219\/2025\/01\/ORN-Icons_internet-copy_internet-copy-300x300-1-65x65.png 65w, https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-content\/uploads\/sites\/219\/2025\/01\/ORN-Icons_internet-copy_internet-copy-300x300-1-225x225.png 225w\" sizes=\"auto, (max-width: 200px) 100vw, 200px\" \/><\/h2>\n<\/header>\n<div class=\"textbox__content\" style=\"text-align: left\">\n<p>Mr. Parker has been receiving gentamicin 80 mg IV three times daily to treat his infective endocarditis. He has his gentamicin level checked one hour after the end of his previous gentamicin infusion was completed. The result is 30 mcg\/mL. Access the information below to determine the nurse&#8217;s course of action.<\/p>\n<p><a class=\"arrow\" href=\"https:\/\/medlineplus.gov\/ency\/article\/003430.htm\" target=\"_blank\" rel=\"noopener noreferrer\">View information on therapeutic drug levels.<\/a><\/p>\n<p><em> (After accessing the information, be sure to select \u201cclick to keep reading\u201d in order to view drugs that are commonly checked, their target levels, and what abnormal results mean.)<\/em><\/p>\n<p>Based on the results in the above client scenario, what action will the nurse take based on the result of the gentamicin level of 30 mcg\/mL?<\/p>\n<\/div>\n<p>Note: Answers to the Critical Thinking activities can be found in the &#8220;<a href=\"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/chapter\/chapter-1\/\" target=\"_blank\" rel=\"noopener\">Answer Key<\/a>&#8221; section at the end of the book.<\/p>\n<p>&nbsp;<\/p>\n<\/div>\n<\/div>\n<hr class=\"before-footnotes clear\" \/><div class=\"footnotes\"><ol><li id=\"footnote-51-1\">\u201c<a href=\"https:\/\/commons.wikimedia.org\/wiki\/File:Theuraputic_window.png\" target=\"_blank\" rel=\"noopener\">Therapeutic Window<\/a>\u201d\u00a0by Shefaa Alasfoor is licensed under\u00a0<a href=\"https:\/\/creativecommons.org\/licenses\/by-sa\/3.0\/\" target=\"_blank\" rel=\"noopener noreferrer\">CC BY-SA 3.0<\/a><span style=\"font-size: 12.8px\"> <a href=\"#return-footnote-51-1\" class=\"return-footnote\" aria-label=\"Return to footnote 1\">&crarr;<\/a><\/li><li id=\"footnote-51-2\">This work is a derivative of <a href=\"https:\/\/med.libretexts.org\/Bookshelves\/Pharmacology_and_Medicine\/Book%3A_Principles_of_Pharmacology_(OCW)\" target=\"_blank\" rel=\"noopener noreferrer\">Principles of Pharmacology<\/a> by <a href=\"https:\/\/libretexts.org\/\" target=\"_blank\" rel=\"noopener noreferrer\">LibreTexts<\/a> and is licensed under <a href=\"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/\" target=\"_blank\" rel=\"noopener noreferrer\">CC BY-NC-SA 4.0<\/a> <a href=\"#return-footnote-51-2\" class=\"return-footnote\" aria-label=\"Return to footnote 2\">&crarr;<\/a><\/li><\/ol><\/div><div class=\"glossary\"><span class=\"screen-reader-text\" id=\"definition\">definition<\/span><template id=\"term_51_479\"><div class=\"glossary__definition\" role=\"dialog\" data-id=\"term_51_479\"><div tabindex=\"-1\"><p>The dosing window in which the safest and most effective treatment will occur.<\/p>\n<\/div><button><span aria-hidden=\"true\">&times;<\/span><span class=\"screen-reader-text\">Close definition<\/span><\/button><\/div><\/template><template id=\"term_51_721\"><div class=\"glossary__definition\" role=\"dialog\" data-id=\"term_51_721\"><div tabindex=\"-1\"><p>The process of adjusting the dose of a of medication for maximum benefit and least risk of complication.<\/p>\n<\/div><button><span aria-hidden=\"true\">&times;<\/span><span class=\"screen-reader-text\">Close definition<\/span><\/button><\/div><\/template><template id=\"term_51_477\"><div class=\"glossary__definition\" role=\"dialog\" data-id=\"term_51_477\"><div tabindex=\"-1\"><p>When the maximum concentration of drug is in the body.<\/p>\n<\/div><button><span aria-hidden=\"true\">&times;<\/span><span class=\"screen-reader-text\">Close definition<\/span><\/button><\/div><\/template><template id=\"term_51_722\"><div class=\"glossary__definition\" role=\"dialog\" data-id=\"term_51_722\"><div tabindex=\"-1\"><p>A level of blood that is drawn when the medication is at the lowest level in the bloodstream.<\/p>\n<\/div><button><span aria-hidden=\"true\">&times;<\/span><span class=\"screen-reader-text\">Close definition<\/span><\/button><\/div><\/template><template id=\"term_51_480\"><div class=\"glossary__definition\" role=\"dialog\" data-id=\"term_51_480\"><div tabindex=\"-1\"><p>A measurement of the amount of drug that produces a therapeutic effect compared to the amount of drug that produces a toxic effect.<\/p>\n<\/div><button><span aria-hidden=\"true\">&times;<\/span><span class=\"screen-reader-text\">Close definition<\/span><\/button><\/div><\/template><\/div>","protected":false},"author":83,"menu_order":10,"template":"","meta":{"pb_show_title":"on","pb_short_title":"","pb_subtitle":"","pb_authors":[],"pb_section_license":""},"chapter-type":[48],"contributor":[],"license":[],"class_list":["post-51","chapter","type-chapter","status-publish","hentry","chapter-type-numberless"],"part":21,"_links":{"self":[{"href":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/51","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-json\/pressbooks\/v2\/chapters"}],"about":[{"href":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-json\/wp\/v2\/types\/chapter"}],"author":[{"embeddable":true,"href":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-json\/wp\/v2\/users\/83"}],"version-history":[{"count":2,"href":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/51\/revisions"}],"predecessor-version":[{"id":739,"href":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/51\/revisions\/739"}],"part":[{"href":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-json\/pressbooks\/v2\/parts\/21"}],"metadata":[{"href":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/51\/metadata\/"}],"wp:attachment":[{"href":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-json\/wp\/v2\/media?parent=51"}],"wp:term":[{"taxonomy":"chapter-type","embeddable":true,"href":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-json\/pressbooks\/v2\/chapter-type?post=51"},{"taxonomy":"contributor","embeddable":true,"href":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-json\/wp\/v2\/contributor?post=51"},{"taxonomy":"license","embeddable":true,"href":"https:\/\/pressbooks.ccconline.org\/accnursingpharmacology\/wp-json\/wp\/v2\/license?post=51"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}